CX-904 / CytomX, Amgen 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CX-904 / CytomX, Amgen
CTMX-904-101, NCT05387265: A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors

Recruiting
1
100
US
CX-904
CytomX Therapeutics
Solid Tumors
08/25
08/25

Download Options